Secondary prevention of stroke is important: but all hypertensive drugs are not created equal?
Strandberg
Timo E
TE
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000818:Animals; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000188:drug therapy; D002986:Clinical Trials as Topic; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D002546:Ischemic Attack, Transient / Q000473:pathology*; D009203:Myocardial Infarction / Q000209:etiology; D012107:Research Design; D012306:Risk; D020521:Stroke / Q000473:pathology* / Q000517:prevention & control*
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents